Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 31 May 2021
Revised: 10 June 2021
Accepted: 15 June 2021
First Online: 5 July 2021
Declarations
:
: DNL has received compensation for being a content expert for the Society of Immunotherapy of Cancer. DNL has also received compensation for multiple immunotherapy toxicity presentations from the PeerView Institute for Medical Education. The rest of the authors declare no conflicts of interest in this study.
